Hydrochloric Acid → HCID 18470687, Verbindung

HRID 2228639Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2228639
[CH:1]1[CH:2]=[CH:3][C:4]2[C:10](=[O:11])[N:9]([CH:12]3[C:18](=[O:19])[N:17](CO)[C:15](=[O:16])[CH2:14][CH2:13]3)[C:7](=[O:8])[C:5]=2[CH:6]=1.[C:22]1(=O)[O:27][C:25](=[O:26])[CH2:24][CH2:23]1.C(N(CC)CC)C.N1(C2C=CN=CC=2)CCCC1.Cl.C1C=CC2C(=O)N(C3[C:65](=[O:66])NC(=O)CC3)C(=O)C=2C=1.[OH2:67]>ClCCl.C(OCC)(=O)C>[O:8]=[C:7]1[C:5]2[C:4](=[CH:3][CH:2]=[CH:1][CH:6]=2)[C:10](=[O:11])[N:9]1[CH:12]1[CH2:13][CH2:14][C:15](=[O:16])[N:17]([C:24]([C:25]([O:27][CH3:22])=[O:26])([CH3:23])[C:65]([OH:66])=[O:67])[C:18]1=[O:19]

Komponenten

10

Versuchsvorschrift

2.88 g (10 mmoles) N-hydroxymethylthalidomide, 2 g (20 mmoles) succinic anhydride, 2.8 ml (20 mmoles) triethylamine and 0.15 g (1 mmole) 4-pyrrolidinopyridine were stirred in 50 ml dry dichloromethane for 24 hours at room temperature. The reaction mixture was subsequently shaken firstly with 5% hydrochloric acid and then with water. After drying the organic phases over magnesium sulphate and removing the solvent by distillation, the residue obtained was treated with a small amount of ethyl acetate and the precipitated crystals were recrystallised from ethanol 2.66 g (68% theoretical) of compound 9 were obtained, with a melting point of 143 to 146° C. and a solubility in water of 16.7 mg/ml, corresponding to 11.1 mg thalidomide/ml.

Aufarbeitung

  1. dry with materialAfter drying the organic phases over magnesium sulphate
  2. customremoving the solvent
  3. distillationby distillation
  4. customthe residue obtained
  5. customthe precipitated crystals were recrystallised from ethanol 2.66 g (68% theoretical) of compound 9
  6. customwere obtained, with a melting point of 143 to 146° C.

Quellen und Nachweise

ORD-Eintrag
ord-3c428310b8a6480a81b32c17b7a28c6e
Quelldatensatz
uspto-grants-2002_07
Patentnummer
US06417197B1

Notizen zur Reaktion

Wird geladen…